Trends in coronary thrombolytic therapy for acute myocardial infarction (The Minnesota Heart Survey Registry, 1990 to 1993)

American Journal of Cardiology

Volumn 78, Issue 3, 1996, Pages 271-277

  Rosamond, Wayne D ^a,b,c   Shahar, Eyal ^a,b   McGovern, Paul G ^a,b   Sides, Tracy L ^a,b   Luepker, Russell V ^a,b  

^a University of North Carolina ^*  (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEMOPTYSIS; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES;

EID: 0030220562     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00276-7     Document Type: Article

References (28)

1. AIMS Trial Study Group Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet. 1:1988;545-549.
2. ISIS-2 Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 2:1988;349-360.
3. The ISAM study group A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med. 314:1986;1465-1467.
4. Kennedy J, Ritchie J, Davis K, Fritz J Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med. 309:1983;1477-1482.
5. GISSI-2 A factorial reandomized trial of alteplase vesus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction. Lancet. 336:1990;65-71.
6. ISIS-3 Collaborative Group. ISIS-3: A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet. 339:1992;753-770.
7. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
8. LATE Study Group Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 342:1993;759-766.
9. EMERAS Collaborative Group Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet. 342:1993;767-772.
10. Ketley D, Woods K Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 342:1993;891-894.
11. Plotnick G, Ziskind A, Vogel R Survey of practicing cardiologists in Maryland on their choice of thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 69:1992;327-330.
12. Rogers W, Bowlby L, Chandra N, French W, Gore J, Lambrew C, Rudison M, Teifenbrunn A, Weaver W Treatment of myocardial infarction in the United States (1990-1993): Observations from the National Registry of Myocardial Infarction. Circulation. 90:1994;2103-2114.
13. Brodin E, Shahar E, Rosamond W, McGovern P, Spra f ka J, Doliszny K, Luepker R Apparently coronary heart disease-free patients in the coronary care unit: characteristics, medical care, and 1-year outcome. Coron Artery Dis. 5:1994;737-743.
14. SAS Institute Inc. SAS/STAT Guide, Version 6, 4th Edition. Cary, NC 1989.
15. Tsuyuki R, Teo K, Ikuta R, Bay K, Greenwood P, Montague T Mortality risk and patterns of practice in 2,070 patients with acute myocardial infarction, 1987-92. Relative importance of age, sex, and medical therapy. Chest. 105:1994;1687-1892.
16. Behar S, Gottlieb S, Hod H, Narinsky R, Benari B, Rechavia E, Pauzner H Influence of gender in the therapeutic management of patients with acute myocardial infarction in Israel. The Israeli Thrombolytic Survey Group. Am J Cardiol. 73:1994;438-443.
17. Shahar E, Lewis M, Keil U, McGovern P, Lowel H, Spra f ka J, Luepker R Hospital care and survival of acute myocardial infarction patients in Minnesota and Southern Germany: A comparative study (abstr). Circulation. 89:1994;935.
18. Lear J, Lawrence I, Pohl J, Burden A Myocardial infarction and thrombolysis: a comparison of the Indian and European population on a coronary care unit. J Roy Coll Physicians Lond. 28:1994;143-147.
19. Muller D, Topol E Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med. 113:1990;949-960.
20. Pankow J, McGovern P, Shahar E, Luepker R, Blackburn H The role of thrombolytic therapy in improved short-term survival of hospitalized myocardial infarction patients between 1985 and 1990: The Minnesota Heart Survey (abstr). Circulation. 89:1994;935.
21. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overiview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 343:1994;311-322.
22. Grines C, DeMaria A Optimal utilization of thrombolytic therapy for acute myocardial infarction: concepts and controversies. J Am Coll Cardiol. 16:1990;223-231.
23. Pagley P, Yarzebsji J, Golberg R, Chen Z, Chiriboga D, Dalen P, Gurwitz J, Alpert J, Gore J Gender differences in the treatment of patients with acute myocardial infarction: A multihospital community-based perspective. Arch Intern Med. 153:1993;625-629.
24. Maynard C, Althouse R, Cerqueira M, Olsu f ka M, Kennedy J Underutilization of thrombolytic therpay in eligible women with acute myocardial infarction. Am J Cardiol. 68:1991;529-530.
25. Kereiakes D, Weaver W, Anderson J Time delays in the diangosis and treatment of acute myocardial infarction: A tale of eight cities, report from the pre-hospital study group and the Cincinnati Heart Project. Am Heart J. 120:1990;773-779.
26. Emergency Cardiac Care Committee and Subcommittees-American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, III: adult advanced cardiac life support JAMA. 268:1992;2199-2241.
27. Ayanian J, Hauptman P, Guadagnoli E, Antman E, Pashos C, McNeil B Knowledge and practices of generalist and specialist physicians regarding drug therapies for acute myocardial infarction. N Engl J Med. 331:1994;1136-1142.
28. Gruppo Italiano Per Lo Studio Della Streptochinasi Nell'Infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.